文献速递衰弱、肌少症与跌倒认知障碍与谵妄老年慢病共病管理

高龄老人降压治疗中较低收缩压与全因死亡率和认知下降加速相关

Lower blood pressure during antihypertensive treatment is associated with higher all-cause mortality and accelerated cognitive decline in the oldest-old. Data from the Leiden 85-plus Study.
PubMed 文献 · Age Ageing · 2018-01-01

本研究基于Leiden 85-plus人群队列,纳入570名85岁及以上老年人,其中249人(44%)接受降压治疗。在接受降压治疗者中,收缩压每低10 mmHg与全因死亡率升高(HR 1.29,95%CI 1.15-1.46,P<0.001)及认知功能下降加速(年均变化-0.35分,95%CI -0.60至-0.11,P=0.004)相关;未治疗者中无显著关联。

要点

  • 接受降压治疗的高龄老人,收缩压每低10 mmHg全因死亡风险增加29%。
  • 接受降压治疗者收缩压每低10 mmHg,MMSE年均多下降0.35分。
  • 握力较低者认知下降更快;未治疗者中血压与结局无显著关联。

核心结论

  • 在接受降压治疗的高龄老人中,较低收缩压与更高的全因死亡率和更快的认知功能下降相关。
  • 在未接受降压治疗的高龄老人中,血压与死亡率和认知下降无显著关联。

研究设计与样本

  • 基于人群的Leiden 85-plus队列研究,纳入570名85岁及以上参与者,其中249人(44%)接受降压治疗。
  • 基线收缩压和降压治疗使用为预测变量,全因死亡率和MMSE测量的认知功能变化为结局,握力作为身体衰弱的替代指标。
  • 采用Cox比例风险模型和混合效应线性回归分析,敏感性分析排除1年内死亡并限制于无心血管疾病史者。

主要发现

  • 接受降压治疗者中,收缩压每低10 mmHg全因死亡率更高(HR 1.29,95%CI 1.15-1.46,P<0.001)。
  • 接受降压治疗者中,收缩压每低10 mmHg认知功能年均多下降0.35分(95%CI -0.60至-0.11,P=0.004)。
  • 握力较低者认知功能下降更迅速。
  • 未接受降压治疗者中,血压与死亡率或认知下降均无显著关联。

关键数值与推荐

  • 接受降压治疗者:收缩压每低10 mmHg,全因死亡HR 1.29(95%CI 1.15-1.46,P<0.001)。
  • 接受降压治疗者:收缩压每低10 mmHg,MMSE年均变化-0.35分(95%CI -0.60至-0.11,P=0.004)。

临床怎么用

  • 对高龄老人降压治疗时,需关注较低收缩压可能与死亡和认知下降风险相关。
  • 评估握力等衰弱指标可能有助于识别认知下降更快的高风险高龄老人。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: the appropriateness of lowering systolic blood pressure remains controversial in the oldest-old. We tested whether systolic blood pressure is associated with all-cause mortality and change in cognitive function for patients prescribed antihypertensive treatment and those without treatment. METHODS: we studied participants in the population-based Leiden 85-plus cohort study. Baseline systolic blood pressure and use of antihypertensive treatment were predictors; all-cause mortality and change in cognitive function measured using the Mini-Mental State Examination were the outcomes. Grip strength was measured as a proxy for physical frailty. We used Cox proportional hazards and mixed-effects linear regression models to analyse the relationship between systolic blood pressure and both time to death and change in cognitive function. In sensitivity analyses, we excluded deaths within 1 year and restricted analyses to participants without a history of cardiovascular disease. RESULTS: of 570 participants, 249 (44%) were prescribed antihypertensive therapy. All-cause mortality was higher in participants with lower blood pressure prescribed antihypertensive treatment (HR 1.29 per 10 mmHg lower systolic blood pressure, 95% CI 1.15-1.46, P < 0.001). Participants taking antihypertensives showed an association between accelerated cognitive decline and lower blood pressure (annual mean change -0.35 points per 10 mmHg lower systolic blood pressure, 95% CI -0.60, -0.11, P = 0.004); decline in cognition was more rapid in those with lower hand grip strength. In participants not prescribed antihypertensive treatment, no significant associations were seen between blood pressure and either mortality or cognitive decline. CONCLUSIONS: lower systolic blood pressure in the oldest-old taking antihypertensives was associated with higher mortality and faster decline in cognitive function.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Streit S, Poortvliet RKE, Gussekloo J, et al. Lower blood pressure during antihypertensive treatment is associated with higher all-cause mortality and accelerated cognitive decline in the oldest-old. Data from the Leiden 85-plus Study. Age Ageing. 2018. PMID: 29741555. doi:10.1093/ageing/afy072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。